Arizona State Pension System buys 367 shares of Inspire Medical Systems, Inc. (NYSE:INSP)

VaselineSeptember 13, 2024

0 4 minutes read

Arizona State Retirement System grew its position in shares of Inspire Medical Systems, Inc. (NYSE:INSP – Free Report) by 4.5% in the second quarter, HoldingsChannel reports. The firm owned 8,481 shares of the company’s stock after acquiring an additional 367 shares during the period. Arizona State Retirement System’s holdings in Inspire Medical Systems were worth $1,135,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Van ECK Associates Corp raised its position in Inspire Medical Systems by 7.5% in the second quarter. Van ECK Associates Corp now owns 1,029 shares of the company’s stock valued at $138,000 after purchasing an additional 72 shares in the last quarter. Bessemer Group Inc. grew its position in Inspire Medical Systems by 1.2% in the first quarter. Bessemer Group Inc. now owns 8,475 shares of the company’s stock valued at $1,820,000 after buying an additional 100 shares in the last quarter. State Treasurer of North Carolina grew its position in Inspire Medical Systems by 1.0% during the 4th quarter. State Treasurer of North Carolina now owns 12,750 shares of the company’s stock, valued at $2,594,000 after buying another 120 shares in the last quarter. Gilliland Jeter Wealth Management LLC raised its position in Inspire Medical Systems by 0.8% during the 2nd quarter. Gilliland Jeter Wealth Management LLC now owns 15,508 shares of the company’s stock valued at $2,075,000 after buying an additional 125 shares during the period. of shares in the last quarter. Finally, SouthState Corp bought a new stake in Inspire Medical Systems during the second quarter valued at $27,000. 94.91% of shares are owned by institutional investors.

Insider buying and selling at Inspire Medical Systems

In other Inspire Medical Systems news, Director Shawn Mccormick sold 800 shares of the business’s stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $220.00, for a total transaction of $176,000.00. Following the sale, the director now owns 23,140 shares in the company, valued at approximately $5,090,800. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC’s website. In other Inspire Medical Systems news, Director Shawn Mccormick sold 800 shares of the business’s stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $220.00, for a total transaction of $176,000.00. Following the sale, the director now owns 23,140 shares in the company, valued at approximately $5,090,800. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC’s website. Also, insider Randy Ban sold 4,861 shares of the company’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $188.55, for a total value of $916,541.55. Following the completion of the sale, the insider now owns 3,056 shares in the company, valued at approximately $576,208.80. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 5,692 shares of company stock worth $1,099,207. 4.10% of shares are currently owned by insiders.

Inspire Medical Systems Price Performance

Want more great investment ideas?

Shares of INSP stock opened at $203.54 on Friday. Inspire Medical Systems, Inc. has a 1 year low of $123.00 and a 1 year high of $257.40. The stock’s fifty-day moving average price is $167.73 and its 200-day moving average price is $180.94. The company has a market cap of $6.07 billion, a price-to-earnings ratio of -370.07 and a beta of 1.33.

Inspire Medical Systems (NYSE:INSP – Get Your Free Report ) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.46. The business had revenue of $195.89 million for the quarter, compared to the consensus estimate of $189.08 million. Inspire Medical Systems had a return on equity of 1.03% and a net margin of 0.85%. The company’s quarterly revenue was up 29.6% compared to the same quarter last year. In the same quarter last year, the business earned ($0.41) EPS. As a group, equities research analysts anticipate that Inspire Medical Systems, Inc. will post 0.75 earnings per share for the current year.

Analysts on Wall Street are forecasting an increase

Several research analysts recently commented on the company. Robert W. Baird cut their price target on Inspire Medical Systems from $220.00 to $200.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. Morgan Stanley cut their price target on Inspire Medical Systems from $250.00 to $210.00 and set an “overweight” rating for the company in a research report on Monday, July 15th. KeyCorp cut their price target on Inspire Medical Systems from $278.00 to $236.00 and set an “overweight” rating for the company in a research report on Wednesday, August 7th. Truist Financial cut their price target on Inspire Medical Systems from $280.00 to $217.00 and set a “buy” rating for the company in a research report on Tuesday, July 16th. Finally, Stifel Nicolaus cut their price target on Inspire Medical Systems from $210.00 to $170.00 and set a “hold” rating for the company in a research report on Monday, June 24th . Five research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Inspire Medical Systems currently has an average rating of “Moderate Buy” and an average target price of $214.85, according to MarketBeat data.

Get the latest report on Inspire Medical Systems

Inspire Medical Systems Company Profile

(Free Report)

Inspire Medical Systems, Inc., a medical technology company, is focused on developing and commercializing minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers the Inspire System, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.